Provided by Tiger Trade Technology Pte. Ltd.

Petros Pharmaceuticals, Inc.

0.0077
+0.00033.98%
Volume:250.94K
Turnover:2.02K
Market Cap:326.27K
PE:0.00
High:0.0087
Open:0.0073
Low:0.0070
Close:0.0074
52wk High:16.25
52wk Low:0.0017
Shares:42.37M
Float Shares:42.29M
Volume Ratio:1.79
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2061
EPS(LYR):-83.4693
ROE:-565.29%
ROA:-48.91%
PB:0.10
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Petros Pharmaceuticals, Inc.
Exchange:
PINK LIMITED
Establishment Date:
- -
Employees:
18
Office Location:
1185 Avenue of the Americas,3rd Floor,New York,New York,United States
Zip Code:
10036
Fax:
- -
Introduction:
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, PreBoost, VenoSeal, penile injections, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.